Quantcast

Latest Gene therapy Stories

2013-10-21 23:29:16

Cato Research regulatory expert William Lee, Ph.D., R.A.C., Vice President of Regulatory Affairs at Cato Research, will present in San Francisco, California at the OMICS Group Conference, 3rd International Conference on Pharmaceutical Regulatory Affairs. Durham, NC (PRWEB) October 21, 2013 Cato Research regulatory expert William Lee, Ph.D., R.A.C., Vice President of Regulatory Affairs at Cato Research, will present in San Francisco, California at the OMICS Group Conference, 3rd...

2013-10-18 23:00:43

Co-founder and President Barbara Netter thanks donors for supporting ground-breaking and life-saving research. More than 100 prominent donors, scientists, biotech representatives, and physicians attended Alliance for Cancer Gene Therapy’s “Achieving Cancer Remission with Cell and Gene Therapies” Tuesday night at the Harvard Club of New York City. New York, NY and Stamford, CT (PRWEB) October 18, 2013 More than 100 prominent donors, scientists, biotech representatives, and physicians...

2013-10-16 11:53:21

Vitelliform macular dystrophy, also known as Best disease, is one of a group of vision-robbing conditions called bestrophinopathies that affect children and young adults. Caused by inherited mutations in the BEST1 gene, these diseases cause severe declines in central vision as patients age. With a new study, University of Pennsylvania researchers report "encouraging" findings that mark the first clear step in developing a gene therapy that could prevent vision loss or event restore vision...

2013-10-11 23:01:25

World-class Research Fellows and Physicians to Present at the Harvard Club Oct.15 New York, NY and Stamford, CT (PRWEB) October 11, 2013 Alliance for Cancer Gene Therapy (ACGT), a not-for-profit dedicated exclusively to funding research for cancer treatments using cell and gene therapies, will host “Achieving Cancer Remission with Cell and Gene Therapies” on Tuesday, October 15 at the Harvard Club of New York City, 35 W. 44th Street. ACGT is renowned for devoting 100-percent of funds...

2013-10-11 12:01:09

A research team from Dana-Farber/Boston Children's Cancer and Blood Disorders Center and other institutions has discovered a new genetic target for potential therapy of sickle cell disease (SCD). The target, called an enhancer, controls a molecular switch in red blood cells called BCL11A that, in turn, regulates hemoglobin production. The researchers—led by Daniel Bauer, MD, PhD, and Stuart Orkin, MD, of Dana-Farber/Boston Children's—reported their findings today in Science. Prior...

2013-10-03 23:23:47

Reportbuyer.com just published a new market research report: Global Gene Therapy Market Analysis. London (PRWEB) October 03, 2013 Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the most sought after research objectives for ‘difficult to cure’ diseases. The gene therapy market in spite of presenting few marketable products and being...

2013-10-01 23:27:22

American Gene Technologies uses cutting-edge gene therapy to attack virus. Rockville, Maryland (PRWEB) October 01, 2013 Almost 70 million people have been infected with the HIV virus since the beginning of the epidemic, and AIDS has claimed approximately 35 million lives, according to the World Health Organization. With nearly 36 million people around the globe living with HIV, American Gene Technologies International Inc. (AGT) is on a mission to use cutting-edge viral vectors and...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.